与肥胖相关的饮食行为和身体活动在埃及曼苏拉大学的医学学生中
Amira S Nowara1, Hend Magdy2, Mervat M El-Eshmawy1
1Internal Medicine Department, Mansoura Specialized Medical Hospital, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Porto biomedical journal
|March 4, 2025
概括
医学学生面临着超重和肥胖的高风险. 关键的风险因素包括女性的性别,不活动和情绪饮食模式,突出了针对性干预的必要性.
科学领域:
- 医学教育 医学教育
- 公共卫生 公共卫生
- 行为科学 行为科学
背景情况:
- 医学学生由于生活方式因素而面临肥胖的风险.
- 有问题的饮食行为,如情绪性饮食,很普遍.
- 埃及对这一人口群体的数据有限.
研究的目的:
- 确定在埃及曼苏拉大学医学学生中超重和肥胖的患病率.
- 评估与体重状况相关的饮食行为和体力活动水平.
- 在这个人群中确定超重和肥胖的预测因素.
主要方法:
- 这是一项涉及368名医学本科生的横截面研究.
- 使用三因素饮食问卷-R18 (法语翻译) 评估的饮食行为.
- 根据世卫组织指导方针评估的超重,肥胖和体育活动.
主要成果:
- 超重和肥胖的患病率为44% (32%超重,12%肥胖).
- 超重/肥胖的学生表现出较低的体力活动和较高的认知克制,不受控制的饮食和情绪饮食的得分.
- 女性性别,身体不活动,以及较高的认知/情感饮食分数预测了肥胖.
结论:
- 很大一部分医学学生超重或肥胖.
- 关键的危险因素包括女性的性别,身体不活动,以及特定的饮食行为 (认知和情绪的克制).
- 研究结果强调了解决生活方式和行为因素在医学学生中预防肥胖的重要性.
相关概念视频
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Bulimia Nervosa
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
Binge Eating Disorders
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...


